nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—migraine—Prednisone—multiple sclerosis	0.741	1	CpDpCtD
Frovatriptan—HTR1B—trigeminal nucleus—multiple sclerosis	0.0347	0.282	CbGeAlD
Frovatriptan—HTR1D—trigeminal nucleus—multiple sclerosis	0.0336	0.273	CbGeAlD
Frovatriptan—HTR1D—meninx—multiple sclerosis	0.0223	0.182	CbGeAlD
Frovatriptan—HTR1B—trigeminal nerve—multiple sclerosis	0.00912	0.0742	CbGeAlD
Frovatriptan—HTR1D—trigeminal nerve—multiple sclerosis	0.00883	0.0718	CbGeAlD
Frovatriptan—HTR1B—brainstem—multiple sclerosis	0.00143	0.0116	CbGeAlD
Frovatriptan—HTR1D—brainstem—multiple sclerosis	0.00138	0.0113	CbGeAlD
Frovatriptan—HTR1A—brainstem—multiple sclerosis	0.00115	0.00938	CbGeAlD
Frovatriptan—HTR1B—midbrain—multiple sclerosis	0.000911	0.00741	CbGeAlD
Frovatriptan—HTR1B—spinal cord—multiple sclerosis	0.000889	0.00723	CbGeAlD
Frovatriptan—HTR1D—midbrain—multiple sclerosis	0.000882	0.00718	CbGeAlD
Frovatriptan—HTR1B—nervous system—multiple sclerosis	0.000749	0.00609	CbGeAlD
Frovatriptan—HTR1A—midbrain—multiple sclerosis	0.000735	0.00598	CbGeAlD
Frovatriptan—HTR1D—nervous system—multiple sclerosis	0.000725	0.0059	CbGeAlD
Frovatriptan—HTR1B—central nervous system—multiple sclerosis	0.000721	0.00587	CbGeAlD
Frovatriptan—HTR1A—spinal cord—multiple sclerosis	0.000718	0.00584	CbGeAlD
Frovatriptan—HTR1D—central nervous system—multiple sclerosis	0.000698	0.00568	CbGeAlD
Frovatriptan—HTR1A—nervous system—multiple sclerosis	0.000605	0.00492	CbGeAlD
Frovatriptan—HTR1A—central nervous system—multiple sclerosis	0.000582	0.00473	CbGeAlD
Frovatriptan—HTR1B—brain—multiple sclerosis	0.000573	0.00466	CbGeAlD
Frovatriptan—HTR1A—cerebellum—multiple sclerosis	0.000569	0.00463	CbGeAlD
Frovatriptan—HTR1D—brain—multiple sclerosis	0.000554	0.00451	CbGeAlD
Frovatriptan—HTR1A—brain—multiple sclerosis	0.000462	0.00376	CbGeAlD
Frovatriptan—Convulsion—Prednisolone—multiple sclerosis	0.000179	0.00152	CcSEcCtD
Frovatriptan—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000178	0.00151	CcSEcCtD
Frovatriptan—Fatigue—Mitoxantrone—multiple sclerosis	0.000177	0.0015	CcSEcCtD
Frovatriptan—Arrhythmia—Dexamethasone—multiple sclerosis	0.000177	0.0015	CcSEcCtD
Frovatriptan—Arrhythmia—Betamethasone—multiple sclerosis	0.000177	0.0015	CcSEcCtD
Frovatriptan—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000176	0.00149	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000176	0.00149	CcSEcCtD
Frovatriptan—Pain—Mitoxantrone—multiple sclerosis	0.000175	0.00149	CcSEcCtD
Frovatriptan—Constipation—Mitoxantrone—multiple sclerosis	0.000175	0.00149	CcSEcCtD
Frovatriptan—Bradycardia—Prednisone—multiple sclerosis	0.000175	0.00149	CcSEcCtD
Frovatriptan—Diarrhoea—Azathioprine—multiple sclerosis	0.000174	0.00148	CcSEcCtD
Frovatriptan—Discomfort—Prednisolone—multiple sclerosis	0.000173	0.00147	CcSEcCtD
Frovatriptan—Haemoglobin—Prednisone—multiple sclerosis	0.000173	0.00147	CcSEcCtD
Frovatriptan—Haemorrhage—Prednisone—multiple sclerosis	0.000172	0.00146	CcSEcCtD
Frovatriptan—Malaise—Triamcinolone—multiple sclerosis	0.000171	0.00145	CcSEcCtD
Frovatriptan—Malaise—Methylprednisolone—multiple sclerosis	0.000171	0.00145	CcSEcCtD
Frovatriptan—Vertigo—Triamcinolone—multiple sclerosis	0.00017	0.00145	CcSEcCtD
Frovatriptan—Syncope—Triamcinolone—multiple sclerosis	0.00017	0.00144	CcSEcCtD
Frovatriptan—Vertigo—Methylprednisolone—multiple sclerosis	0.00017	0.00144	CcSEcCtD
Frovatriptan—Syncope—Methylprednisolone—multiple sclerosis	0.00017	0.00144	CcSEcCtD
Frovatriptan—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000169	0.00144	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000168	0.00143	CcSEcCtD
Frovatriptan—Dizziness—Azathioprine—multiple sclerosis	0.000168	0.00143	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000168	0.00143	CcSEcCtD
Frovatriptan—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000167	0.00142	CcSEcCtD
Frovatriptan—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000166	0.00141	CcSEcCtD
Frovatriptan—Shock—Prednisolone—multiple sclerosis	0.000166	0.00141	CcSEcCtD
Frovatriptan—Convulsion—Triamcinolone—multiple sclerosis	0.000164	0.0014	CcSEcCtD
Frovatriptan—Tachycardia—Prednisolone—multiple sclerosis	0.000164	0.0014	CcSEcCtD
Frovatriptan—Convulsion—Methylprednisolone—multiple sclerosis	0.000164	0.00139	CcSEcCtD
Frovatriptan—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000163	0.00138	CcSEcCtD
Frovatriptan—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000162	0.00138	CcSEcCtD
Frovatriptan—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000162	0.00138	CcSEcCtD
Frovatriptan—Myalgia—Triamcinolone—multiple sclerosis	0.000161	0.00137	CcSEcCtD
Frovatriptan—Vomiting—Azathioprine—multiple sclerosis	0.000161	0.00137	CcSEcCtD
Frovatriptan—Arthralgia—Methylprednisolone—multiple sclerosis	0.000161	0.00137	CcSEcCtD
Frovatriptan—Myalgia—Methylprednisolone—multiple sclerosis	0.000161	0.00137	CcSEcCtD
Frovatriptan—Anxiety—Methylprednisolone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Frovatriptan—Depression—Methotrexate—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Frovatriptan—Flushing—Prednisone—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Frovatriptan—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Frovatriptan—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Frovatriptan—Discomfort—Triamcinolone—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Frovatriptan—Discomfort—Methylprednisolone—multiple sclerosis	0.000159	0.00135	CcSEcCtD
Frovatriptan—Headache—Azathioprine—multiple sclerosis	0.000159	0.00135	CcSEcCtD
Frovatriptan—Dry mouth—Triamcinolone—multiple sclerosis	0.000158	0.00134	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—multiple sclerosis	0.000156	0.00133	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—multiple sclerosis	0.000156	0.00132	CcSEcCtD
Frovatriptan—Confusional state—Methylprednisolone—multiple sclerosis	0.000156	0.00132	CcSEcCtD
Frovatriptan—Malaise—Betamethasone—multiple sclerosis	0.000155	0.00132	CcSEcCtD
Frovatriptan—Malaise—Dexamethasone—multiple sclerosis	0.000155	0.00132	CcSEcCtD
Frovatriptan—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000155	0.00131	CcSEcCtD
Frovatriptan—Vertigo—Dexamethasone—multiple sclerosis	0.000155	0.00131	CcSEcCtD
Frovatriptan—Vertigo—Betamethasone—multiple sclerosis	0.000155	0.00131	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000154	0.00131	CcSEcCtD
Frovatriptan—Syncope—Betamethasone—multiple sclerosis	0.000154	0.00131	CcSEcCtD
Frovatriptan—Syncope—Dexamethasone—multiple sclerosis	0.000154	0.00131	CcSEcCtD
Frovatriptan—Arrhythmia—Prednisone—multiple sclerosis	0.000154	0.00131	CcSEcCtD
Frovatriptan—Shock—Triamcinolone—multiple sclerosis	0.000152	0.00129	CcSEcCtD
Frovatriptan—Insomnia—Prednisolone—multiple sclerosis	0.000152	0.00129	CcSEcCtD
Frovatriptan—Shock—Methylprednisolone—multiple sclerosis	0.000152	0.00129	CcSEcCtD
Frovatriptan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisolone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Tachycardia—Triamcinolone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Mental disorder—Prednisone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Nausea—Azathioprine—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000151	0.00128	CcSEcCtD
Frovatriptan—Malnutrition—Prednisone—multiple sclerosis	0.00015	0.00127	CcSEcCtD
Frovatriptan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00015	0.00127	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000149	0.00127	CcSEcCtD
Frovatriptan—Convulsion—Betamethasone—multiple sclerosis	0.000149	0.00127	CcSEcCtD
Frovatriptan—Convulsion—Dexamethasone—multiple sclerosis	0.000149	0.00127	CcSEcCtD
Frovatriptan—Asthenia—Mitoxantrone—multiple sclerosis	0.000147	0.00125	CcSEcCtD
Frovatriptan—Myalgia—Dexamethasone—multiple sclerosis	0.000147	0.00124	CcSEcCtD
Frovatriptan—Myalgia—Betamethasone—multiple sclerosis	0.000147	0.00124	CcSEcCtD
Frovatriptan—Anxiety—Dexamethasone—multiple sclerosis	0.000146	0.00124	CcSEcCtD
Frovatriptan—Anxiety—Betamethasone—multiple sclerosis	0.000146	0.00124	CcSEcCtD
Frovatriptan—Discomfort—Betamethasone—multiple sclerosis	0.000145	0.00123	CcSEcCtD
Frovatriptan—Discomfort—Dexamethasone—multiple sclerosis	0.000145	0.00123	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—multiple sclerosis	0.000145	0.00123	CcSEcCtD
Frovatriptan—Pain—Prednisolone—multiple sclerosis	0.000144	0.00122	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—multiple sclerosis	0.000144	0.00122	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—multiple sclerosis	0.000143	0.00121	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000142	0.00121	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—multiple sclerosis	0.000141	0.0012	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000141	0.0012	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000141	0.0012	CcSEcCtD
Frovatriptan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00014	0.00119	CcSEcCtD
Frovatriptan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00014	0.00119	CcSEcCtD
Frovatriptan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00014	0.00119	CcSEcCtD
Frovatriptan—Insomnia—Triamcinolone—multiple sclerosis	0.00014	0.00119	CcSEcCtD
Frovatriptan—Insomnia—Methylprednisolone—multiple sclerosis	0.00014	0.00119	CcSEcCtD
Frovatriptan—Ill-defined disorder—Prednisone—multiple sclerosis	0.000139	0.00118	CcSEcCtD
Frovatriptan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000139	0.00118	CcSEcCtD
Frovatriptan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000139	0.00118	CcSEcCtD
Frovatriptan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000139	0.00118	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—multiple sclerosis	0.000139	0.00118	CcSEcCtD
Frovatriptan—Shock—Dexamethasone—multiple sclerosis	0.000138	0.00117	CcSEcCtD
Frovatriptan—Shock—Betamethasone—multiple sclerosis	0.000138	0.00117	CcSEcCtD
Frovatriptan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000138	0.00117	CcSEcCtD
Frovatriptan—Agitation—Prednisone—multiple sclerosis	0.000138	0.00117	CcSEcCtD
Frovatriptan—Tachycardia—Dexamethasone—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Frovatriptan—Tachycardia—Betamethasone—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Frovatriptan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000136	0.00116	CcSEcCtD
Frovatriptan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000136	0.00115	CcSEcCtD
Frovatriptan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000136	0.00115	CcSEcCtD
Frovatriptan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000136	0.00115	CcSEcCtD
Frovatriptan—Malaise—Prednisone—multiple sclerosis	0.000135	0.00115	CcSEcCtD
Frovatriptan—Vertigo—Prednisone—multiple sclerosis	0.000135	0.00114	CcSEcCtD
Frovatriptan—Syncope—Prednisone—multiple sclerosis	0.000134	0.00114	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—multiple sclerosis	0.000134	0.00114	CcSEcCtD
Frovatriptan—Anorexia—Dexamethasone—multiple sclerosis	0.000134	0.00114	CcSEcCtD
Frovatriptan—Anorexia—Betamethasone—multiple sclerosis	0.000134	0.00114	CcSEcCtD
Frovatriptan—Fatigue—Triamcinolone—multiple sclerosis	0.000133	0.00113	CcSEcCtD
Frovatriptan—Fatigue—Methylprednisolone—multiple sclerosis	0.000133	0.00113	CcSEcCtD
Frovatriptan—Pain—Triamcinolone—multiple sclerosis	0.000132	0.00112	CcSEcCtD
Frovatriptan—Loss of consciousness—Prednisone—multiple sclerosis	0.000132	0.00112	CcSEcCtD
Frovatriptan—Vomiting—Mitoxantrone—multiple sclerosis	0.00013	0.00111	CcSEcCtD
Frovatriptan—Convulsion—Prednisone—multiple sclerosis	0.00013	0.0011	CcSEcCtD
Frovatriptan—Chills—Methotrexate—multiple sclerosis	0.000129	0.0011	CcSEcCtD
Frovatriptan—Headache—Mitoxantrone—multiple sclerosis	0.000129	0.00109	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000128	0.00109	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000128	0.00109	CcSEcCtD
Frovatriptan—Arthralgia—Prednisone—multiple sclerosis	0.000128	0.00108	CcSEcCtD
Frovatriptan—Myalgia—Prednisone—multiple sclerosis	0.000128	0.00108	CcSEcCtD
Frovatriptan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000128	0.00108	CcSEcCtD
Frovatriptan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000127	0.00108	CcSEcCtD
Frovatriptan—Anxiety—Prednisone—multiple sclerosis	0.000127	0.00108	CcSEcCtD
Frovatriptan—Insomnia—Dexamethasone—multiple sclerosis	0.000127	0.00108	CcSEcCtD
Frovatriptan—Insomnia—Betamethasone—multiple sclerosis	0.000127	0.00108	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000126	0.00107	CcSEcCtD
Frovatriptan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000126	0.00107	CcSEcCtD
Frovatriptan—Paraesthesia—Betamethasone—multiple sclerosis	0.000126	0.00107	CcSEcCtD
Frovatriptan—Discomfort—Prednisone—multiple sclerosis	0.000126	0.00107	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—multiple sclerosis	0.000126	0.00107	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—multiple sclerosis	0.000125	0.00106	CcSEcCtD
Frovatriptan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Frovatriptan—Dyspepsia—Betamethasone—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Frovatriptan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—multiple sclerosis	0.000123	0.00104	CcSEcCtD
Frovatriptan—Body temperature increased—Triamcinolone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Decreased appetite—Betamethasone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Decreased appetite—Dexamethasone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Nausea—Mitoxantrone—multiple sclerosis	0.000122	0.00104	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—multiple sclerosis	0.000121	0.00103	CcSEcCtD
Frovatriptan—Fatigue—Betamethasone—multiple sclerosis	0.000121	0.00103	CcSEcCtD
Frovatriptan—Fatigue—Dexamethasone—multiple sclerosis	0.000121	0.00103	CcSEcCtD
Frovatriptan—Shock—Prednisone—multiple sclerosis	0.00012	0.00102	CcSEcCtD
Frovatriptan—Pain—Dexamethasone—multiple sclerosis	0.00012	0.00102	CcSEcCtD
Frovatriptan—Pain—Betamethasone—multiple sclerosis	0.00012	0.00102	CcSEcCtD
Frovatriptan—Tachycardia—Prednisone—multiple sclerosis	0.000119	0.00101	CcSEcCtD
Frovatriptan—Hyperhidrosis—Prednisone—multiple sclerosis	0.000118	0.001	CcSEcCtD
Frovatriptan—Anorexia—Prednisone—multiple sclerosis	0.000117	0.00099	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000116	0.000987	CcSEcCtD
Frovatriptan—Feeling abnormal—Betamethasone—multiple sclerosis	0.000116	0.000983	CcSEcCtD
Frovatriptan—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000116	0.000983	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000115	0.000976	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000115	0.000976	CcSEcCtD
Frovatriptan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000114	0.000969	CcSEcCtD
Frovatriptan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000114	0.000967	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—multiple sclerosis	0.000113	0.000959	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—multiple sclerosis	0.000113	0.000956	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000111	0.000947	CcSEcCtD
Frovatriptan—Dizziness—Prednisolone—multiple sclerosis	0.000111	0.000945	CcSEcCtD
Frovatriptan—Asthenia—Triamcinolone—multiple sclerosis	0.000111	0.000943	CcSEcCtD
Frovatriptan—Abdominal pain—Betamethasone—multiple sclerosis	0.000111	0.000943	CcSEcCtD
Frovatriptan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000111	0.000943	CcSEcCtD
Frovatriptan—Body temperature increased—Betamethasone—multiple sclerosis	0.000111	0.000943	CcSEcCtD
Frovatriptan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000111	0.000943	CcSEcCtD
Frovatriptan—Asthenia—Methylprednisolone—multiple sclerosis	0.000111	0.000941	CcSEcCtD
Frovatriptan—Insomnia—Prednisone—multiple sclerosis	0.000111	0.00094	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisone—multiple sclerosis	0.00011	0.000933	CcSEcCtD
Frovatriptan—Pruritus—Triamcinolone—multiple sclerosis	0.00011	0.00093	CcSEcCtD
Frovatriptan—Pruritus—Methylprednisolone—multiple sclerosis	0.000109	0.000928	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—multiple sclerosis	0.000109	0.000922	CcSEcCtD
Frovatriptan—Dyspepsia—Prednisone—multiple sclerosis	0.000108	0.000915	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—multiple sclerosis	0.000107	0.000906	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—multiple sclerosis	0.000107	0.000906	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—multiple sclerosis	0.000107	0.000906	CcSEcCtD
Frovatriptan—Decreased appetite—Prednisone—multiple sclerosis	0.000106	0.000903	CcSEcCtD
Frovatriptan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000106	0.000898	CcSEcCtD
Frovatriptan—Fatigue—Prednisone—multiple sclerosis	0.000105	0.000896	CcSEcCtD
Frovatriptan—Headache—Prednisolone—multiple sclerosis	0.000105	0.000896	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—multiple sclerosis	0.000105	0.000895	CcSEcCtD
Frovatriptan—Constipation—Prednisone—multiple sclerosis	0.000105	0.000888	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—multiple sclerosis	0.000103	0.000876	CcSEcCtD
Frovatriptan—Dizziness—Triamcinolone—multiple sclerosis	0.000102	0.000869	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000102	0.000868	CcSEcCtD
Frovatriptan—Dizziness—Methylprednisolone—multiple sclerosis	0.000102	0.000868	CcSEcCtD
Frovatriptan—Feeling abnormal—Prednisone—multiple sclerosis	0.000101	0.000856	CcSEcCtD
Frovatriptan—Asthenia—Betamethasone—multiple sclerosis	0.000101	0.000856	CcSEcCtD
Frovatriptan—Asthenia—Dexamethasone—multiple sclerosis	0.000101	0.000856	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.0001	0.00085	CcSEcCtD
Frovatriptan—Nausea—Prednisolone—multiple sclerosis	0.0001	0.000849	CcSEcCtD
Frovatriptan—Pruritus—Dexamethasone—multiple sclerosis	9.94e-05	0.000844	CcSEcCtD
Frovatriptan—Pruritus—Betamethasone—multiple sclerosis	9.94e-05	0.000844	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—multiple sclerosis	9.88e-05	0.000839	CcSEcCtD
Frovatriptan—Vomiting—Triamcinolone—multiple sclerosis	9.84e-05	0.000836	CcSEcCtD
Frovatriptan—Vomiting—Methylprednisolone—multiple sclerosis	9.82e-05	0.000834	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—multiple sclerosis	9.74e-05	0.000828	CcSEcCtD
Frovatriptan—Headache—Triamcinolone—multiple sclerosis	9.7e-05	0.000824	CcSEcCtD
Frovatriptan—Headache—Methylprednisolone—multiple sclerosis	9.68e-05	0.000822	CcSEcCtD
Frovatriptan—Abdominal pain—Prednisone—multiple sclerosis	9.67e-05	0.000821	CcSEcCtD
Frovatriptan—Body temperature increased—Prednisone—multiple sclerosis	9.67e-05	0.000821	CcSEcCtD
Frovatriptan—Diarrhoea—Dexamethasone—multiple sclerosis	9.61e-05	0.000816	CcSEcCtD
Frovatriptan—Diarrhoea—Betamethasone—multiple sclerosis	9.61e-05	0.000816	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.31e-05	0.000791	CcSEcCtD
Frovatriptan—Dizziness—Betamethasone—multiple sclerosis	9.29e-05	0.000789	CcSEcCtD
Frovatriptan—Dizziness—Dexamethasone—multiple sclerosis	9.29e-05	0.000789	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—multiple sclerosis	9.25e-05	0.000785	CcSEcCtD
Frovatriptan—Nausea—Triamcinolone—multiple sclerosis	9.19e-05	0.000781	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—multiple sclerosis	9.18e-05	0.00078	CcSEcCtD
Frovatriptan—Nausea—Methylprednisolone—multiple sclerosis	9.17e-05	0.000779	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—multiple sclerosis	9.11e-05	0.000774	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—multiple sclerosis	9.09e-05	0.000772	CcSEcCtD
Frovatriptan—Hypersensitivity—Prednisone—multiple sclerosis	9.01e-05	0.000765	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—multiple sclerosis	9e-05	0.000764	CcSEcCtD
Frovatriptan—Vomiting—Betamethasone—multiple sclerosis	8.93e-05	0.000759	CcSEcCtD
Frovatriptan—Vomiting—Dexamethasone—multiple sclerosis	8.93e-05	0.000759	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—multiple sclerosis	8.89e-05	0.000755	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—multiple sclerosis	8.81e-05	0.000749	CcSEcCtD
Frovatriptan—Headache—Betamethasone—multiple sclerosis	8.8e-05	0.000747	CcSEcCtD
Frovatriptan—Headache—Dexamethasone—multiple sclerosis	8.8e-05	0.000747	CcSEcCtD
Frovatriptan—Asthenia—Prednisone—multiple sclerosis	8.78e-05	0.000745	CcSEcCtD
Frovatriptan—Pain—Methotrexate—multiple sclerosis	8.74e-05	0.000743	CcSEcCtD
Frovatriptan—Pruritus—Prednisone—multiple sclerosis	8.65e-05	0.000735	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—multiple sclerosis	8.42e-05	0.000716	CcSEcCtD
Frovatriptan—Diarrhoea—Prednisone—multiple sclerosis	8.37e-05	0.000711	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.36e-05	0.00071	CcSEcCtD
Frovatriptan—Nausea—Dexamethasone—multiple sclerosis	8.34e-05	0.000709	CcSEcCtD
Frovatriptan—Nausea—Betamethasone—multiple sclerosis	8.34e-05	0.000709	CcSEcCtD
Frovatriptan—Dizziness—Prednisone—multiple sclerosis	8.09e-05	0.000687	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—multiple sclerosis	8.08e-05	0.000686	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—multiple sclerosis	8.08e-05	0.000686	CcSEcCtD
Frovatriptan—Vomiting—Prednisone—multiple sclerosis	7.78e-05	0.000661	CcSEcCtD
Frovatriptan—Headache—Prednisone—multiple sclerosis	7.66e-05	0.000651	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—multiple sclerosis	7.53e-05	0.00064	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—multiple sclerosis	7.33e-05	0.000623	CcSEcCtD
Frovatriptan—Nausea—Prednisone—multiple sclerosis	7.26e-05	0.000617	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—multiple sclerosis	7.23e-05	0.000614	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—multiple sclerosis	6.99e-05	0.000594	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—multiple sclerosis	6.76e-05	0.000574	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—multiple sclerosis	6.5e-05	0.000552	CcSEcCtD
Frovatriptan—Headache—Methotrexate—multiple sclerosis	6.4e-05	0.000544	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—multiple sclerosis	6.07e-05	0.000516	CcSEcCtD
Frovatriptan—HTR1D—G alpha (i) signalling events—POMC—multiple sclerosis	4.56e-05	0.00245	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCL10—multiple sclerosis	4.56e-05	0.00245	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.54e-05	0.00244	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.53e-05	0.00243	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL3—multiple sclerosis	4.52e-05	0.00243	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LINGO1—multiple sclerosis	4.52e-05	0.00243	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—POMC—multiple sclerosis	4.47e-05	0.0024	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	4.46e-05	0.0024	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL10—multiple sclerosis	4.46e-05	0.0024	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—S1PR1—multiple sclerosis	4.42e-05	0.00237	CbGpPWpGaD
Frovatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.4e-05	0.00236	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL13—multiple sclerosis	4.37e-05	0.00235	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR1—multiple sclerosis	4.37e-05	0.00235	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—PTGER4—multiple sclerosis	4.35e-05	0.00234	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CCR5—multiple sclerosis	4.35e-05	0.00234	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL13—multiple sclerosis	4.28e-05	0.0023	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR1—multiple sclerosis	4.28e-05	0.0023	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCR3—multiple sclerosis	4.21e-05	0.00226	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RGS1—multiple sclerosis	4.14e-05	0.00222	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCR2—multiple sclerosis	4.09e-05	0.0022	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	4.04e-05	0.00217	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.04e-05	0.00217	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.02e-05	0.00216	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAGAP—multiple sclerosis	4e-05	0.00215	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL5—multiple sclerosis	3.92e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GPR65—multiple sclerosis	3.92e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAGAP—multiple sclerosis	3.92e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.84e-05	0.00206	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL5—multiple sclerosis	3.84e-05	0.00206	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CNR1—multiple sclerosis	3.78e-05	0.00203	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RGS1—multiple sclerosis	3.76e-05	0.00202	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.63e-05	0.00195	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR1—multiple sclerosis	3.59e-05	0.00193	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL13—multiple sclerosis	3.59e-05	0.00193	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.57e-05	0.00192	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GPR65—multiple sclerosis	3.56e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.55e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.55e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCR5—multiple sclerosis	3.53e-05	0.0019	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.5e-05	0.00188	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—S1PR1—multiple sclerosis	3.5e-05	0.00188	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.47e-05	0.00187	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.46e-05	0.00186	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCR5—multiple sclerosis	3.46e-05	0.00186	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LINGO1—multiple sclerosis	3.44e-05	0.00185	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—S1PR1—multiple sclerosis	3.43e-05	0.00184	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GPC5—multiple sclerosis	3.4e-05	0.00183	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—POMC—multiple sclerosis	3.4e-05	0.00183	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL10—multiple sclerosis	3.4e-05	0.00183	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GPC5—multiple sclerosis	3.33e-05	0.00179	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PTGER4—multiple sclerosis	3.3e-05	0.00177	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR1—multiple sclerosis	3.26e-05	0.00175	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL13—multiple sclerosis	3.26e-05	0.00175	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.23e-05	0.00174	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.23e-05	0.00174	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	3.23e-05	0.00173	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCR3—multiple sclerosis	3.19e-05	0.00171	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.15e-05	0.00169	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.14e-05	0.00169	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	3.12e-05	0.00168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL3—multiple sclerosis	3.11e-05	0.00167	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCR2—multiple sclerosis	3.1e-05	0.00166	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.08e-05	0.00165	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL3—multiple sclerosis	3.05e-05	0.00164	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCR2—multiple sclerosis	3.03e-05	0.00163	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PTGER4—multiple sclerosis	3e-05	0.00161	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAGAP—multiple sclerosis	2.99e-05	0.0016	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RGS1—multiple sclerosis	2.98e-05	0.0016	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PTGER4—multiple sclerosis	2.93e-05	0.00158	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.93e-05	0.00157	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.93e-05	0.00157	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL5—multiple sclerosis	2.93e-05	0.00157	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RGS1—multiple sclerosis	2.91e-05	0.00156	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCR3—multiple sclerosis	2.89e-05	0.00155	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CNR1—multiple sclerosis	2.86e-05	0.00154	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCR3—multiple sclerosis	2.83e-05	0.00152	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GPR65—multiple sclerosis	2.82e-05	0.00152	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR2—multiple sclerosis	2.81e-05	0.00151	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CNR1—multiple sclerosis	2.8e-05	0.0015	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GPR65—multiple sclerosis	2.76e-05	0.00148	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—POMC—multiple sclerosis	2.76e-05	0.00148	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR2—multiple sclerosis	2.76e-05	0.00148	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.71e-05	0.00145	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—POMC—multiple sclerosis	2.7e-05	0.00145	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL2—multiple sclerosis	2.7e-05	0.00145	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.65e-05	0.00142	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL2—multiple sclerosis	2.65e-05	0.00142	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	2.64e-05	0.00142	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	2.61e-05	0.0014	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CNR1—multiple sclerosis	2.6e-05	0.0014	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL13—multiple sclerosis	2.58e-05	0.00139	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR1—multiple sclerosis	2.58e-05	0.00139	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL10—multiple sclerosis	2.58e-05	0.00138	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CNR1—multiple sclerosis	2.54e-05	0.00137	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.54e-05	0.00137	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	2.54e-05	0.00136	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR1—multiple sclerosis	2.53e-05	0.00136	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL13—multiple sclerosis	2.53e-05	0.00136	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	2.52e-05	0.00135	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	2.46e-05	0.00132	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	2.38e-05	0.00128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL10—multiple sclerosis	2.34e-05	0.00126	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	2.32e-05	0.00125	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	2.31e-05	0.00124	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL10—multiple sclerosis	2.29e-05	0.00123	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	2.23e-05	0.0012	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	2.22e-05	0.00119	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCL5—multiple sclerosis	2.22e-05	0.00119	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	2.17e-05	0.00117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	2.16e-05	0.00116	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	2.13e-05	0.00115	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	2.1e-05	0.00113	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	2.1e-05	0.00113	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	2.06e-05	0.00111	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.05e-05	0.0011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SRM—multiple sclerosis	2.04e-05	0.0011	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	2.02e-05	0.00108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL5—multiple sclerosis	2.01e-05	0.00108	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCR5—multiple sclerosis	2e-05	0.00107	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	1.97e-05	0.00106	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL2RA—multiple sclerosis	1.97e-05	0.00106	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	1.96e-05	0.00105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	1.94e-05	0.00104	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	1.93e-05	0.00104	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	1.92e-05	0.00103	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	1.92e-05	0.00103	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	1.92e-05	0.00103	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.89e-05	0.00102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL3—multiple sclerosis	1.84e-05	0.000987	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR5—multiple sclerosis	1.81e-05	0.000974	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	1.8e-05	0.000967	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL2RA—multiple sclerosis	1.79e-05	0.00096	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	1.78e-05	0.000954	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTGER4—multiple sclerosis	1.77e-05	0.00095	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	1.75e-05	0.00094	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	1.74e-05	0.000937	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PGR—multiple sclerosis	1.74e-05	0.000936	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	1.73e-05	0.000931	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCR3—multiple sclerosis	1.71e-05	0.000918	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PGR—multiple sclerosis	1.71e-05	0.000917	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CD28—multiple sclerosis	1.69e-05	0.000909	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	1.67e-05	0.000899	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR2—multiple sclerosis	1.66e-05	0.000893	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CD28—multiple sclerosis	1.66e-05	0.00089	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.65e-05	0.000888	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	1.63e-05	0.000874	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—POMC—multiple sclerosis	1.56e-05	0.000838	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CNR1—multiple sclerosis	1.53e-05	0.000824	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	1.53e-05	0.000821	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	1.5e-05	0.000807	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	1.5e-05	0.000807	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.49e-05	0.0008	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.47e-05	0.000789	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.44e-05	0.000774	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.44e-05	0.000774	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—POMC—multiple sclerosis	1.42e-05	0.000761	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.41e-05	0.000756	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	1.39e-05	0.000745	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL2—multiple sclerosis	1.39e-05	0.000745	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL10—multiple sclerosis	1.38e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	1.37e-05	0.000737	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.36e-05	0.000729	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	1.35e-05	0.000727	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.35e-05	0.000727	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.33e-05	0.000716	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	1.32e-05	0.000709	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.32e-05	0.000708	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PGR—multiple sclerosis	1.3e-05	0.000698	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.27e-05	0.000685	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.26e-05	0.000678	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	1.26e-05	0.000676	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	1.24e-05	0.000666	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	1.23e-05	0.000662	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CD86—multiple sclerosis	1.21e-05	0.000649	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	1.19e-05	0.000639	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CD86—multiple sclerosis	1.18e-05	0.000635	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	1.16e-05	0.000625	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.16e-05	0.000625	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	1.15e-05	0.00062	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.14e-05	0.000615	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000607	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	0.000592	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.09e-05	0.000586	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	1.08e-05	0.000579	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	0.000575	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.06e-05	0.000568	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	1.06e-05	0.000567	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	1.05e-05	0.000563	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	1.05e-05	0.000563	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.03e-05	0.000556	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	1.03e-05	0.000555	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.03e-05	0.000553	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	1.03e-05	0.000551	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—multiple sclerosis	9.75e-06	0.000524	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—multiple sclerosis	9.54e-06	0.000513	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	9.39e-06	0.000505	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CD86—multiple sclerosis	9.01e-06	0.000484	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	8.87e-06	0.000476	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CD80—multiple sclerosis	8.81e-06	0.000473	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CD80—multiple sclerosis	8.63e-06	0.000463	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	8.61e-06	0.000462	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.47e-06	0.000455	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—multiple sclerosis	8.37e-06	0.00045	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	8.21e-06	0.000441	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—multiple sclerosis	8.2e-06	0.00044	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	8.19e-06	0.00044	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	8.02e-06	0.000431	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	8.02e-06	0.000431	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	7.99e-06	0.000429	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	7.88e-06	0.000423	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	7.85e-06	0.000422	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	7.82e-06	0.00042	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	7.44e-06	0.0004	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	7.28e-06	0.000391	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.28e-06	0.000391	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—multiple sclerosis	7.27e-06	0.00039	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.63e-06	0.000356	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CD80—multiple sclerosis	6.57e-06	0.000353	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.27e-06	0.000337	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—multiple sclerosis	6.25e-06	0.000335	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2—multiple sclerosis	6.19e-06	0.000332	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	6.16e-06	0.000331	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	6.11e-06	0.000328	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2—multiple sclerosis	6.06e-06	0.000326	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	6.03e-06	0.000324	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	5.98e-06	0.000321	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	5.86e-06	0.000315	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	5.74e-06	0.000308	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	5.55e-06	0.000298	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	5.21e-06	0.00028	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	5.1e-06	0.000274	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—multiple sclerosis	4.84e-06	0.00026	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	4.83e-06	0.000259	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—multiple sclerosis	4.74e-06	0.000255	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	4.74e-06	0.000254	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	4.73e-06	0.000254	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	4.64e-06	0.000249	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2—multiple sclerosis	4.62e-06	0.000248	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	4.59e-06	0.000247	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	4.37e-06	0.000235	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	3.89e-06	0.000209	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—multiple sclerosis	3.77e-06	0.000203	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—multiple sclerosis	3.64e-06	0.000195	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—multiple sclerosis	3.61e-06	0.000194	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	3.6e-06	0.000193	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—multiple sclerosis	3.56e-06	0.000191	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	3.53e-06	0.00019	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—multiple sclerosis	3.24e-06	0.000174	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—multiple sclerosis	2.95e-06	0.000159	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—multiple sclerosis	2.71e-06	0.000146	CbGpPWpGaD
